Skip to main contentSkip to navigation
Sirius Investors
Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
NASDAQHealthcare

AGRX Financial Statements & Analysis

Complete financial statements for AGRX including income statement, balance sheet, and cash flow statement. Analyze AGRX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
0.3%
Net Income
-103.5%
Gross Margin
6.5%
Operating Margin
15.2%

Balance Sheet

Current Ratio
-1.5%
Debt to Equity
64.0%
Asset Turnover
-15.4%

Cash Flow

Operating Cash Flow
83.7%
Net Cash Flow
103.5%
Free Cash Flow
83.7%
Cash Flow to Debt
78.7%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q1 '24TTM Q2 '24ChangeImpact
Revenue21.50M21.57M0.3%
Gross Profit12.84M13.72M6.9%
Operating Income-15.94M-13.55M14.9%
Net Income-7.79M-15.86M103.5%
EPS-0.63-0.9144.0%
EBITDA-6.20M-5.60M9.6%
Gross Margin59.73%63.63%6.5%
Operating Margin-74.13%-62.85%15.2%
Net Income Margin-36.26%-73.52%102.8%
R&D Expenses1.96M1.79M8.4%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q2 '24TTM Q1 '24TTM Q4 '23TTM Q3 '23TTM Q2 '23
Revenue21.57M21.50M19.59M
Gross Profit13.72M12.84M10.61M
Operating Income-13.55M-15.94M-19.89M
Net Income-15.86M-7.79M-12.69M
EPS-0.91-0.63-1.48
EBITDA-5.60M-6.20M-12.66M
Gross Margin63.63%59.73%54.18%
Operating Margin-62.85%-74.13%-101.50%
Net Income Margin-73.52%-36.26%-64.76%
R&D Expenses1.79M1.96M2.23M

Our detailed financial analysis helps investors understand AGRX's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track AGRX's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into AGRX's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Agile Therapeutics, Inc. (AGRX) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors